Søgning på udtrykket 'influenza' giver 48 resultater
Dokumenter [2] Sider [2] Kalender [3] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [2]
Version 8 (21.11.22) Udarbejdet af Dansk Selskab for Infektionsmedicin i samarbejde med Dansk Selskab for Klinisk Mikrobiologi, Dansk Hæmatologisk Selskab, Dansk Pædiatrisk Selskab, Dansk Selskab for Almen Medicin, Dansk Lungemedicinsk Selskab, Dansk Selskab for Obstetrik og Gynækologi, Dansk Transplantationsselskab, Dansk Selskab for Klinisk Onkologi & Fagligt Selskab for Hygiejnesygeplejersker
Bl.a. om HIV, hepatitis, influenza og CNS infektioner
Sider [2]
…nti-TNF-alfa (2011), Tjekliste ved screening før behandling med anti-TNF-alpha, Indvandrermedicin: Chalotte Stecher (tovholder), Hanne Nødgaard Christensen, Christian Wejse, Jane Agergaard, Morten Sodemann og Marie Nørredam Influenza: Jens Lundgren (tovholder), Thomas Benfield, Jan Gerstoft, Isik Johansen, Gitte Kronborg, Henrik Nielsen, Lene Surland Knudsen, Merete Storgaard og Ole Kirk Influenza, Inspektorordningen i Sundhedsstyrelsen: Hanne Arildsen, Th…
Risikoen for bakteriel infektion og sepsis er svært forhøjet ved manglende miltfunktion som følge af splenektomi samt kongenit eller funktionel aspleni. Alvorlige infektioner skyldes primært Streptococcus pneumoniae, Haemophilus influenzae og Neisseria meningitidis. Risikoen for svær infektion ved malaria og dyrebid er også markant forhøjet. Vaccination, antibiotika profylakse/tidlig behandling og adækvat patient information er afgørende for forebyggelse af infektioner. Antibiotika behandlin…
…der kan smitte gennem upasteuriseret mælk omfatter som bekendt bl.a. brucella, Mycobacterium bovis, Listeria, Q-feber, HEV og TBE. Men nu er også influenza på listen. Udover de vidtrækkende konsekvenser, som fugleinfluenza-infektioner kan have i husdyrhold, så er det altså også nu en sygdom på listen over infektiøse agens, der smitter gennem upasteuriseret ko-mælk. Heldigvis ser det ud til at pasteurisering er effektiv, og det skal også bemærkes, at i artiklen har man kun set på katte og mus.
Kalender [3]
19. april, Statens Serum Institut
24. januar 2019, Aarhus Universitetshospital
9. november 2018, Korsør
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Virulence
26.07.2024
Volume 15, Issue 1, December 2024 .
Nat Rev Microbiol
26.07.2024
Journal of Medical Virology
26.07.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.
Clinical Infectious Diseases
25.07.2024
Abstract . Background . Studies have reported that repeated annual vaccination may influence influenza vaccination effectiveness in the current season.Methods . We established a 5-year randomized placebo-controlled trial of repeated influenza vaccination (Flublok, Sanofi Pasteur) in adults 18-45 years of age. In the first two years, participants received vaccination (V) or saline placebo (P) as follows: P-P, P-V, or V-V. Serum samples were collected each year just before vaccination and after 30 and 182 day…
Emerg Microbes Infect
24.07.2024
Volume 13, Issue 1, December 2024 .
International Journal of Infectious Diseases
21.07.2024
Influenza is a highly contagious airborne disease caused by Influenza type A and type B viruses [1]. Influenza is one of the most common infectious diseases and occurs in seasonal epidemics [2] causing an acute febrile illness with variable degrees of systemic symptoms, ranging from mild fatigue to respiratory failure and death [3]. Although it is a preventable disease, Influenza is one of the main public health concerns worldwide, and during the last decade, awareness towards influenza virus diagnosis and …
Virulence
18.07.2024
Volume 15, Issue 1, December 2024 .
Nature
17.07.2024
PLoS One Infectious Diseases
17.07.2024
by The PLOS ONE Editors .
PLoS One Infectious Diseases
17.07.2024
by Jiho Lee, Chang-Won Lee, David L. Suarez, Scott A. Lee, Taejoong Kim, Erica Spackman . The outbreak of clade 2.3.4.4b H5 highly pathogenic avian influenza (HPAI) in North America that started in 2021 has increased interest in applying vaccination as a strategy to help control and prevent the disease in poultry. Two commercially available vaccines based on the recombinant herpes virus of turkeys (rHVT) vector were tested against a recent North American clade 2.3.4.4b H5 HPAI virus isolate: A/turkey/India…
Journal of Medical Virology
16.07.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.
Infection and Immunity
12.07.2024
Infection and Immunity, Ahead of Print.
Science
12.07.2024
Science, Volume 385, Issue 6705, Page 123-123, July 2024.
Lancet Infectious Diseases
12.07.2024
The H3N2 M2SR vaccine coadministered with Fluzone HD in older adults was well tolerated and provided enhanced immunogenicity compared with Fluzone HD administered alone, suggesting potential for improved efficacy of influenza vaccination in this age group. Additional studies are planned to assess efficacy.
Proceedings of the National Academy of Sciences
10.07.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 28, July 2024.
Journal of Medical Virology
9.07.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.
Emerg Microbes Infect
7.07.2024
Volume 13, Issue 1, December 2024 .
BMC Infectious Diseases
5.07.2024
BMC Infectious Diseases
4.07.2024
International Journal of Infectious Diseases
4.07.2024
Influenza leads to a substantial annual burden due to widespread disease as well as many deaths, particularly in vulnerable populations. It is estimated that influenza results in 9–41 million illnesses, 140,000–710,000 hospitalizations, and 12,000–52,000 deaths in the United States (US) annually [1]. Individuals aged ≥65 years are at greater risk for influenza-related hospitalizations and deaths compared with other age groups, with up to 90% of deaths occurring in those aged ≥65 years [2]. Comorbi…
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Eurosurveillance latest updates
26.07.2024
We investigated the thermostability of four European avian influenza A(H5N1) viruses in whole and semi-skimmed milk and their replication in bovine kidney and lung cells amid the current influenza A(H5N1) dairy cattle outbreak in the United States. Results showed strain-dependent differences in thermal inactivation, particularly in whole milk, and variable replication efficacy in lung cells. These findings support assessing the inactivation of European H5N1 viruses in milk and their replication in bovine ce…
Morbidity and Mortality Weekly Report (MMWR)
25.07.2024
This report describes symptom monitoring and testing among exposed dairy and poultry workers in Michigan during the H5N1 outbreak.
Eurosurveillance latest updates
22.06.2024
Highly pathogenic avian influenza (HPAI) has caused widespread mortality in both wild and domestic birds in Europe 2020–2023. In July 2023, HPAI A(H5N1) was detected on 27 fur farms in Finland. In total, infections in silver and blue foxes, American minks and raccoon dogs were confirmed by RT-PCR. The pathological findings in the animals include widespread inflammatory lesions in the lungs, brain and liver, indicating efficient systemic dissemination of the virus. Phylogenetic analysis of Finnish A(H5N1) …
Eurosurveillance latest updates
22.06.2024
.
Morbidity and Mortality Weekly Report (MMWR)
25.05.2024
This report describes the joint investigation between CDC, U.S. Department of Agriculture, and the Food and Drug Administration after influenza A (H5N1) was detected in a U.S. farm worker.
Medscape Infectious Diseases
18.05.2024
The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday released data on influenza A found in wastewater in a public dashboard that could assist in tracking the. . Reuters Health Information
Eurosurveillance latest updates
26.04.2024
A severe outbreak of influenza A(H1N1pdm09) infection in seven children (median age: 52 months) occurred between December 2023 and January 2024 in Tuscany, Italy. Clinical presentation ranged from milder encephalopathy to acute necrotizing encephalopathy (ANE) with coma and multiorgan failure; one child died. This report raises awareness for clinicians to identify and treat early acute encephalopathy caused by H1N1 influenza and serves as a reminder of severe presentations of influenza in young children and…
Eurosurveillance latest updates
12.04.2024
…ropean Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023–6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI: 91.7–98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season. .
Morbidity and Mortality Weekly Report (MMWR)
29.02.2024
This report describes estimated vaccine effectiveness for laboratory-confirmed flu in California.
Morbidity and Mortality Weekly Report (MMWR)
29.02.2024
This report describes estimates of 2023-24 influenza vaccine effectiveness among different age groups.
Eurosurveillance latest updates
23.02.2024
. Background. Waning immunity from seasonal influenza vaccination can cause suboptimal protection during peak influenza activity. However, vaccine effectiveness studies assessing waning immunity using vaccinated and unvaccinated individuals are subject to biases. . . Aim. We examined the association between time since vaccination and laboratory-confirmed influenza to assess the change in influenza vaccine protection over time. . . Methods. Using linked laboratory and health administrative databases in…
Eurosurveillance latest updates
23.02.2024
Influenza A viruses circulated in Europe from September 2023 to January 2024, with influenza A(H1N1)pdm09 predominance. We provide interim 2023/24 influenza vaccine effectiveness (IVE) estimates from two European studies, covering 10 countries across primary care (EU-PC) and hospital (EU-H) settings. Interim IVE was higher against A(H1N1)pdm09 than A(H3N2): EU-PC influenza A(H1N1)pdm09 IVE was 53% (95% CI: 41 to 63) and 30% (95% CI: −3 to 54) against influenza A(H3N2). For EU-H, these were…
Eurosurveillance latest updates
16.02.2024
The Canadian Sentinel Practitioner Surveillance Network reports mid-season 2023/24 influenza vaccine effectiveness (VE) of 63% (95% CI: 51–72) against influenza A(H1N1)pdm09, lower for clade 5a.2a.1 (56%; 95% CI: 33–71) than clade 5a.2a (67%; 95% CI: 48–80), and lowest against influenza A(H3N2) (40%; 95% CI: 5–61). The Omicron XBB.1.5 vaccine protected comparably well, with VE of 47% (95% CI: 21–65) against medically attended COVID-19, higher among people reporting a prior confirmed SARS…
ECDC COVID-19 updates
15.02.2024
AURORAE provides laboratory support for surveillance, preparedness and response to COVID-19 and influenza and strengthens the capacity for genomic epidemiology and public health bioinformatics through interdisciplinary training, which is crucial for response during a pandemic or unexpected major public health events.
ECDC COVID-19 updates
6.02.2024
This core protocol for ECDC studies of VE against hospitalisation with SARI laboratory-confirmed with SARS-CoV-2 or with influenza, version 3.0, represents an update to the main elements for a multi-country hospital-based study of COVID-19 vaccine effectiveness in patients hospitalised with SARI, initially published as version 1.0 [5], updated to version 2.0 [6].
Eurosurveillance latest updates
26.01.2024
. Background. Influenza was almost absent for 2 years following the implementation of strict public health measures to prevent the spread of SARS-CoV-2. The consequence of this on infections in different age groups is not yet known. . . Aim. To describe the age groups infected with the influenza virus in 2021/22, the first post-pandemic influenza season in Denmark, compared with the previous six seasons, and subtypes circulating therein. . . Methods. Infection and hospitalisation incidences per season…
Eurosurveillance latest updates
19.01.2024
Under International Health Regulations from 2005, a human infection caused by a novel influenza A virus variant is considered an event that has potential for high public health impact and is immediately notifiable to the World Health Organisation. We here describe the clinical, epidemiological and virological features of a confirmed human case of swine influenza A(H1N2)v in England detected through community respiratory virus surveillance. Swabbing and contact tracing helped refine public health risk assess…
Eurosurveillance latest updates
12.01.2024
Timely and precise influenza vaccine effectiveness (VE) estimates are needed to guide public health messaging and impact vaccine uptake immediately. Using routinely collected laboratory, vaccination and health administrative data from Alberta, Canada, we estimated influenza VE against infection for the 2023/24 season on a near real-time basis, to late December, at 61% (95% CI: 58–64) against influenza A(H1N1), 49% (95% CI: 28–63) against influenza A(H3N2) and 75% (95% CI: 58–85) against influenz…
Morbidity and Mortality Weekly Report (MMWR)
21.12.2023
This report describes influenza, updated COVID-19, and respiratory syncytial virus vaccination coverage among adults.
Morbidity and Mortality Weekly Report (MMWR)
21.12.2023
This report describes respiratory syncytial virus, influenza, and COVID-19 vaccination coverage among nursing home residents.